Relative adrenal insufficiency in non-critically ill liver cirrhosis
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260968Keywords:
Adrenal insufficiency, CLD, CTP, MELD, HDL, EtiologyAbstract
Background: Endocrinopathy like adrenal insufficiency (AI) is being increasingly recognised in patients with liver cirrhosis. It is characterized by a relative decrease in serum cortisol level with respect to increasing stress as occurs in sepsis & has been associated with increased morbidity and mortality. This study aimed to find the prevalence of Adrenal insufficiency and low HDL in non-critically ill chronic liver disease (CLD) patients i.e. patients without sepsis, bleed or dehydration.
Methodology: A cross-sectional study including 100 non-critically ill CLD patients aged 20 -80 years. Model for end stage liver disease (MELD) scores and the Child Turcotte Pugh scores (CTP) were used to assess the severity of liver disease. Basal cortisol level was measured & after one hour of short synacthen test (SST), peak and delta cortisol levels were measured in order to assess adrenal function. Biochemical parameters including HDL levels were also assayed.
Results: This study included 76 male and 24 female CLD patients. Prevalence of AI was highest in females of age 41-60 years. Alcohol (61%) was the most common etiology, followed by MASLD and HBV. Prevalence of AI was 55.6%, 60.5% and 65.9% in CTP class A, B and C respectively. Prevalence of AI in the high MELD (>15) group was 66.7% and 50% in the low MELD (<14) group. Low HDL and AI were reported in CTP classes B and C.
Conclusion: Adrenal insufficiency is common in patients with non-critically ill chronic liver disease; which increases with severity of disease; and whose HDL levels are low.
Metrics
References
Marik PE, Gayowski T, Starzl TE. Hepatic Cortisol Research and Adrenal Pathophysiology Study Group. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med. 2005;33(6):1254-9. DOI: https://doi.org/10.1097/01.CCM.0000164541.12106.57
Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283(8):1038-45. DOI: https://doi.org/10.1001/jama.283.8.1038
Clemmesen O, Ott P, Larsen FS. Splanchnic metabolism in acute liver failure and sepsis. Curr Opin Crit Care. 2004;10(2):152-5. DOI: https://doi.org/10.1097/00075198-200404000-00012
Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med. 2009;360(22):2328-39. DOI: https://doi.org/10.1056/NEJMra0804635
Fede G, Spadaro L, Tomaselli T. Assessment of adrenocortical reserve in stable patients with cirrhosis. J Hepatol. 2011;54(2):243-50. DOI: https://doi.org/10.1016/j.jhep.2010.06.034
Orozco F, Anders M, Mella J. Insuficiencia suprarrenal relativa en pacientes cirrótico. Medicina (B Aires). 2016;76(4):208-12.
Galbois A, Rudler M, Massard J, et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol. 2010;52(6):839-45. DOI: https://doi.org/10.1016/j.jhep.2010.01.026
Ooi K, Shiraki K, Sakurai Y, Morishita Y, Nobori T. Clinical significance of abnormal lipoprotein patterns in liver diseases. Int J Mol Med. 2005;15(4):655-60. DOI: https://doi.org/10.3892/ijmm.15.4.655
Etogo-Asse FE, Vincent RP, Hughes SA, et al. High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness. Liver Int. 2012;32(1):128-36. DOI: https://doi.org/10.1111/j.1478-3231.2011.02657.x
Pirillo A, Catapano AL, Norata GD. HDL in infectious diseases and sepsis. Handb Exp Pharmacol. 2015;224:483-508. DOI: https://doi.org/10.1007/978-3-319-09665-0_15
Habib A, Mihas AA, Abou-Assi SG, et al. High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. Clin Gastroenterol Hepatol. 2005;3(3):286-91. DOI: https://doi.org/10.1016/S1542-3565(04)00622-6
Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006;91(12):4849-53. DOI: https://doi.org/10.1210/jc.2006-0076
Trifan A, Chiriac S, Stanciu C. Update on adrenal insufficiency in patients with liver cirrhosis. World J Gastroenterol. 2013;19(4):445-56. DOI: https://doi.org/10.3748/wjg.v19.i4.445
Rushworth RL, Torpy DJ. A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections. BMC Endocr Disord. 2014;14:79. DOI: https://doi.org/10.1186/1472-6823-14-79
Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2010;17(3):217-23. DOI: https://doi.org/10.1097/MED.0b013e328338f608
Rushworth RL, Falhammar H, Torpy DJ. Factors underlying a disproportionate increase in hospital admissions for adrenal insufficiency in women aged 20-29 years. Front Endocrinol (Lausanne). 2023;14:1252577. DOI: https://doi.org/10.3389/fendo.2023.1252577
Paragliola RM, Corsello SM. Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment. Minerva Endocrinol. 2017;43:183-97. DOI: https://doi.org/10.23736/S0391-1977.17.02701-8
Moini M, Yazdani Sarvestani M, Shams M, Nomovi M. Evaluation of Adrenal Function in Nonhospitalized Patients with Cirrhosis. Can J Gastroenterol Hepatol. 2017;2017:2354253. DOI: https://doi.org/10.1155/2017/2354253
Lin MC, Tsai MH, Leu JG. Hyperkalemia in a patient with myasthenia gravis: case presentation. BMC Endocr Disord. 2019;19:80. DOI: https://doi.org/10.1186/s12902-019-0406-z
Hadi R, Ammar R. Sheehan’s syndrome unveiled after decades without a diagnosis: A case report. SAGE Open Medical Case Reports. 2023;10:1177.
Wentworth BJ, Schliep M, Novicoff W, Siragy HM, Geng CX, Henry ZH. Relative adrenal insufficiency in the non-critically ill patient with cirrhosis: A systematic review and meta-analysis. Liver Int. 2023;43(3):660-72. DOI: https://doi.org/10.1111/liv.15473
Marik E, Stephen M. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937-49. DOI: https://doi.org/10.1097/CCM.0b013e31817603ba
Rakici H. Adrenal insufficiency in cirrhosis patients: evaluation of 108 case series. Euroasian J Hepatogastroenterol. 2017;7(2):150-3. DOI: https://doi.org/10.5005/jp-journals-10018-1237
Anastasiadis SN, Giouleme OI, Germanidis GS, Vasiliadis TG. Relative adrenal insufficiency in cirrhotic patients. Clin Med Insights Gastroenterol. 2015;8:13-7. DOI: https://doi.org/10.4137/CGast.S18127
Kaiser T, Kinny-Köster B, Bartels M. Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality. BMC Gastroenterol. 2017;17(1):57. DOI: https://doi.org/10.1186/s12876-017-0614-9
Rao BH, Nair P, Koshy AK, Krishnapriya S, Greeshma CR, Venu RP. Role of HDL-C as a clinical predictor of decompensation in patients with CLD. Int J Hepatol. 2021;2021:1795851. DOI: https://doi.org/10.1155/2021/1795851
Downloads
Published
How to Cite
Issue
Section
